EUVIMEDEUVIMED entdecken
Crossref

IMPACT OF EPISODIC TREATMENT OF PAROXETINE ON DEPRESSIVE-LIKE BEHAVIOR AND ANOREXIA IN RAT MODEL OF UNPREDICTABLE STRESS

Muhammad Farhan, Shoaib Ahmed, Anila Bibi, Syeda Rabab Zehra, Jaweria Kanwal, Ayesha Ahmed Soomro, Mehreen, Zohra Siraj, Nabeel Ahmed Saghir

International Journal of Biology and Biotechnology · 2025

DOI: 10.65014/ijbb.v22iv.19 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biology and Biotechnology, 2025. Verfasst von Muhammad Farhan und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paroxetine belongs to the A phenylpiperidine class of selective serotonin reuptake inhibitors (SSRIs). Compared to other SSRIs such as sertraline, fluoxetine, and fluvoxamine, paroxetine, demonstrates greater selectivity as well as potency. Its pharmacokinetic profile makes it highly suitable for clinical application, having a half-life approximately 24 hours and absence of active metabolites. Similar to other SSRIs, it has minimal clinically relevant drug interactions. Stressful conditions exert a complex influence on neural and physiological processes, often contributing to depression and anxiety. Evidence from both clinical and experimental research indicates that paroxetine effectively reduces moderate to acute depression and related anxiety symptoms, with an onset of action comparable to tricyclic antidepressants. To ascertain paroxetine's anxiety-reducing and appetite-enhancing effects in a rat model of unexpected stress. Male adult rats were divided into stressed as well as unstressed groups. Animals received paroxetine (10 mg/kg/day) for a period of 14 days, one hour prior to stress exposure. Behavioral outcomes, including food intake and elevated plus maze performance, were recorded after the first administration and at weekly intervals. The study investigated whether paroxetine could attenuate stress-induced anorexia and behavioral impairments. Prolonged moderate anxiety produced significant changes in the behavior, which were mitigated by recurrent paroxetine treatment. Stressed animals exhibited depressive-like behaviors, attenuated by paroxetine administration. Food intake in unstressed groups treated with paroxetine was significantly higher than in stressed animals treated with saline treatment, demonstrated hyperphagic effects, with food intake being significantly higher in unstressed than in stressed animals. Paroxetine administration produced significant anxiolytic effects in the elevated plus maze, particularly in unstressed animals.

Zitieren

APA

Farhan, M., Ahmed, S., Bibi, A., Zehra, S. R., Kanwal, J., Soomro, A. A., Mehreen, Siraj, Z., & Saghir, N. A. (2025). IMPACT OF EPISODIC TREATMENT OF PAROXETINE ON DEPRESSIVE-LIKE BEHAVIOR AND ANOREXIA IN RAT MODEL OF UNPREDICTABLE STRESS. International Journal of Biology and Biotechnology. https://doi.org/10.65014/ijbb.v22iv.19

Vancouver

Farhan M, Ahmed S, Bibi A, Zehra SR, Kanwal J, Soomro AA, et al. IMPACT OF EPISODIC TREATMENT OF PAROXETINE ON DEPRESSIVE-LIKE BEHAVIOR AND ANOREXIA IN RAT MODEL OF UNPREDICTABLE STRESS. International Journal of Biology and Biotechnology. 2025. doi:10.65014/ijbb.v22iv.19

BibTeX
@article{Farhan2025,
  author = {Farhan, Muhammad and Ahmed, Shoaib and Bibi, Anila and Zehra, Syeda Rabab and Kanwal, Jaweria and Soomro, Ayesha Ahmed and Mehreen and Siraj, Zohra and Saghir, Nabeel Ahmed},
  title = {IMPACT OF EPISODIC TREATMENT OF PAROXETINE ON DEPRESSIVE-LIKE BEHAVIOR AND ANOREXIA IN RAT MODEL OF UNPREDICTABLE STRESS},
  journal = {International Journal of Biology and Biotechnology},
  year = {2025},
  doi = {10.65014/ijbb.v22iv.19}
}
Kostenlos starten →